Avanish Vellanki's most recent trade in Rain Oncology Inc was a trade of 318,600 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 15, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rain Oncology Inc | Avanish Vellanki | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2023 | 318,600 | 318,600 | - | - | Stock Option (Right to Buy) | |
| Rain Oncology Inc | Avanish Vellanki | Director, Chairman and CEO, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 2.29 per share. | 01 Jun 2022 | 25,000 | 2,471,627 | - | 2.3 | 57,250 | Common Stock |
| Rain Oncology Inc | Avanish Vellanki | Director, Chairman and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Apr 2022 | 59,618 | 2,446,627 | - | 0 | Common Stock | |
| Rain Oncology Inc | Avanish Vellanki | Director, Chairman and CEO, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 14 Apr 2022 | 59,618 | 79,283 | - | 0 | Common Stock | |
| Rain Oncology Inc | Avanish Vellanki | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Mar 2022 | 14,468 | 31,832 | - | - | Stock Option (Right to Buy) | |
| Rain Oncology Inc | Avanish Vellanki | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.00 per share. | 11 Mar 2022 | 14,468 | 2,837,009 | - | 4 | 57,872 | Common Stock |
| Rain Oncology Inc | Avanish Vellanki | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2022 | 182,300 | 182,300 | - | - | Stock Option (Right to Buy) | |
| Rain Oncology Inc | Avanish Vellanki | Director, President and CEO | 27 Apr 2021 | 12,108 | 0 | - | - | Series A Preferred Stock | ||
| Rain Oncology Inc | Avanish Vellanki | Director, President and CEO | 27 Apr 2021 | 11,212 | 2,372,541 | - | - | Common Stock |